Status:
UNKNOWN
The Evaluation of Laser Lancing Devices in Adult Type 2 Diabetes Patients
Lead Sponsor:
Korea University Guro Hospital
Collaborating Sponsors:
Korea Medical Device Development Fund
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
20-79 years
Phase:
NA
Brief Summary
Self monitoring of blood glucose level is crucial in diabetes management, but currently available methods, lancet, have shown low compliance of self monitoring of blood glucose because of pain, kerati...
Detailed Description
Self monitoring of blood glucose level is crucial in diabetes management, so it is important to increase compliance of blood glucose checking. Lancet which is currently available methods have shown lo...
Eligibility Criteria
Inclusion
- Type 2 diabetes patients who visit Korea University medical center, Guro hospital, Ansan hospital
- Patients with Hba1c more than 6.5% and less than 8.5%
- Adults who are able to measure blood glucose level by themselves
- Adults who are able to lance their same finger from both hands
- Adults who comprehend risk of participating in the clinical research, who are able to communicate each other, who are able to follow rules of clinical research
- Subjects who decide to participate in the clinical research voluntarily and sign in the consent format after being informed purposes, methods, expectations of the clinical research
Exclusion
- Subject whose age is younger than 19 or older than 80
- students of research institutes
- Pregnant and lactating women
- Subjects who are not able to make decision
- Subjects who are in emergency or being hospitalized
- Subjects who cannot lance sane finger from both hands
- Subjects who are infected by HIV in hospital records
- Subjects who have thrombocytopenia, coagulation disorder or haemophilia
- Subjects who are incompatible for clinical research as researcher evaluated
Key Trial Info
Start Date :
August 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05251506
Start Date
August 10 2021
End Date
December 31 2022
Last Update
February 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Korea University medical center
Seoul, South Korea, 08308